Blog - Page 954 of 5708 - QualityStocks

MondayJun 27, 2022 2:03 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Expands Collaboration Efforts with Tier 1 Supplier of Automotive Lighting Equipment

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, and Koito Manufacturing Co. Ltd (TSE: 7276), a leading automotive lighting equipment tier-1 supplier, jointly announced their intention to expand existing collaboration efforts to include select future Cepton lidar products and go-to-market activities. According to the update, detailed commercial terms are under discussion. “In the past five years, our team has successfully collaborated with Koito to commercialize and scale the manufacturing of Cepton’s lidar technology,” said Jun Pei, Cepton’s co-founder and CEO. “Expanded collaboration will further strengthen the Koito-Cepton partnership and better positions both companies to…

MondayJun 27, 2022 1:44 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Moving Forward with Phase 1/2a Clinical Trial after Receiving Key FDA Approval

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has received approval from the U.S. Food and Drug Administration (“FDA”) to proceed with its phase 1/2a first-in-human clinical trial evaluating CYB003; the company has received a “may proceed” letter and investigational new drug application (“IND”) clearance from the FDA. The approval means that CYB003 will be the first novel psilocybin analog to enter clinical development, with patient recruitment beginning immediately and pharmacokinetic and safety data readout anticipated by fourth quarter 2022. According to the announcement, Cybin’s CYB003 is a proprietary deuterated psilocybin analog being developed for…

MondayJun 27, 2022 1:34 pm

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Featured in Adelaide Capital Biofuels & Renewable Energy Panel

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, was recently featured in a virtual biofuels & renewables focused session with a keynote followed by three 20-minute company presentations and a 30-minute panel. EverGen’s co-founder and CEO Chase Edgelow joined the session with host Deborah Honig to discuss the portfolio of assets the company has built over the previous two years. EverGen has built these assets with the view that it is operating at the intersection of organic waste, which needs a long-term sustainability focused solution versus traditional land-filling organics, as well as providing green energy through…

MondayJun 27, 2022 12:45 pm

Advanced Container Technologies Inc. (ACTX) GrowPods Strengthen Company’s Position in Growing Multibillion-Dollar Market

The global indoor farming market projected to grow from $26.5 billion in 2021 to $62 billion by 2030 Report indicates that United States holds major share in terms of revenue in North America indoor farming market Grow Pods offered through ACTX provide a controlled environment, ability to grow year-round The newest projections for the global indoor farming sector are in, and the numbers bode well for Advanced Container Technologies (OTC: ACTX). ACTX is the exclusive U.S. distributor of Grow Pods, environmentally controlled micro-farms that allow cultivation of ultra-clean crops all year long. “The study undertaken by Astute Analytica foresees a tremendous growth in revenue of the…

MondayJun 27, 2022 12:00 pm

Cepton, Inc. (NASDAQ: CPTN), a Leader in Lidar, Continues to Execute on its Core Strategic Milestones Across Automotive & Smart Infrastructure

Cepton develops lidar sensors for ADAS and autonomous driving, and has been awarded the largest lidar production contract to date with products set to debut next year across General Motor’s Ultra Cruise ADAS platform Award covers 4 target vehicle models in 2023, 4+ models in 2024, and an anticipated 4+ models in 2025 with Cadillac being the first to introduce the Ultra Cruise technology Cepton’s proprietary MMT(R) technology provides a highly competitive price for performance and reliability Founder-led, visionary management team with substantial “skin in the game” Since becoming public in early 2022, Cepton (NASDAQ: CPTN) has not deviated from…

MondayJun 27, 2022 11:15 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Grows Quarterly Net Income by Over 359% Yoy, Sees Margins Widen by Nearly 43%

Golden Matrix Group recently reported its 15th consecutive quarter of profitability GMGI’s second quarter revenues rose 221% YoY with net income expanding by upwards of 359% YoY GMGI attributed the rise in revenues to the added contribution from UK-based competition company, RKingsCompetitions Ltd, which Golden Matrix acquired in November 2021 Management expressed their continued optimism on GMGI’s future prospects, with the company’s B2B and B2C verticals both showing robust growth Fifteen consecutive quarters of profitability is a remarkable feat; even Amazon, the world's largest e-commerce operator, reported a net loss over the past three months. Moreover, Golden Matrix Group (NASDAQ:…

MondayJun 27, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Reach of its Drug Delivery Technology Through Newly Inked Agreements with Beverage Developer BevNology

Drug delivery technology innovator Lexaria Bioscience has developed a patented technology showing superiority in animal and human testing as a means of improving existing drug brands’ performance and establishing new solutions for unmet medical needs The company recently announced agreements with beverage developer BevNology to expand production capabilities for Lexaria's own growing list of B2B clientele and empowering BevNology to offer DehydraTECH products with active ingredients derived from hemp including CBD under BevNology and partnered brands The technology is called DehydraTECH — improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery Lexaria also…

MondayJun 27, 2022 9:45 am

Odyssey Health, Inc. (ODYY) Targeting Achievement of Important Milestones, as It Progresses Clinical Trials of Novel Concussion Drug

Odyssey Health is focused on developing life-saving medical products and pharmaceutical assets that offer a technological and clinical advantage The company is developing the CardioMap Heart Monitoring and Screening Device and the Save-a-Life choking rescue device Its drug-device combination is intended to get PRV-002, Odyssey’s novel treatment for concussion, to the brain rapidly after concussion In an interview with RedChip Companies CEO Dave Gentry, Odyssey CEO Michael Redmond outlined the timelines under which the company is operating as it eyes the commercialization of its novel drug candidate Medical company Odyssey Health (OTC: ODYY) is working to provide life-saving medical solutions…

MondayJun 27, 2022 9:00 am

Home Bistro Inc.’s (HBIS) Model Meals Brand Unveils New Subscription-Based Plan

New meal plan offering includes three meals a day (breakfast, lunch and dinner) up to five days per week Model Meals brand is optimal for providing seamless customer experience, substantially increased customer lifetime value Move provides opportunity to explore subscription model with other HBIS components, says CEO Home Bistro (OTC: HBIS), a leading online meal-delivery platform that offers exclusive celebrity chef-inspired, gourmet and lifestyle ready-made meals, is strengthening its commitment to offer exclusive celebrity-chef-inspired, ready-made meals by launching its first subscription-based offering for its Model Meals brand (https://ibn.fm/9wDv9). The new plan offering includes three meals a day (breakfast, lunch and…

MondayJun 27, 2022 2:15 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Initial Results from Feasibility Study

Study indicates that ketamine-induced changes in functional connectivity last for several days after administration of the substance Kernel Flow gathers real-time functional brain activity during clinical and research studies evaluating psychedelic-based therapeutics Technology is “precisely what we need to accelerate the development of psychedelics into therapeutics,” says Cybin CEO New data confirms Cybin’s (NEO: CYBN) (NYSE American: CYBN) focus on and commitment to progressing psychedelics to therapeutics. The company’s feasibility study using Kernel Flow confirms the device’s ability to successfully measure the neuro-effect of ketamine (https://ibn.fm/blLwT), based on study results presented at the PSYCH Symposium in London. Cybin has announced that…

Site Search

Company Search